Paclitaxel - Cheplapharm Arzneimittel
At a glance
- Drug Originator National Institutes of Health (USA)
- Drug Licenced by Cheplapharm Arzneimittel
- Drug Class Albumins; Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin polymerisation promoters
- USA Patent Applicants HQ SPCLT PHARMA
- USA Patents 4
- NDAs 1
Table of Contents
Disclaimer